Search PubMed⌕ Search

Biomedical subjects

P Rougier

Publications and source records attributed to P Rougier.

At least 19 recordsLinked to original sources

Arterial phase enhancement and body mass index are predictors of response to chemoembolisation for liver metastases of endocrine tumours.

Transcatheter arterial chemoembolisation (TACE) has been reported to be an efficient treatment of liver metastases of endocrine tumours in short series of patients. However, several factors seem to affect its results. The aim of this work is to identify predictors of response to TACE for liver metastases of endocrine tumours. A total of 163 TACE procedures were performed in 67 patients between 1994 and 2004. Forty-four patients were treated with streptozotocin and 23 with doxorubicin. Primary tumour was located in the pancreas for 19 patients, and had been removed in 43. Thirty-eight tumours were functioning. Response rate was 37% (confidence interval [CI] 95%: 28-49%). Median time to progression (TTP) was 14.5 months (CI 95%: 9-41). In multivariate analysis (n=43), predictors of tumour response were body mass index (BMI) (odds ratio [OR]: 1.3; CI 95%: 1.04-1.63; P=0.022), functioning type of tumour (OR: 7.31; CI 95%: 1.26-42.5; P=0.027), arterial phase enhancement on abdominal computed tomography (CT) (OR: 8.11; CI 95%:1.06-62; P=0.044) and use of streptozotocin for cytotoxic agent (OR: 21.3; CI 95%: 1.48-306; P=0.025). Analysis of TTP predictors showed that BMI (hazard ratio [HR]: 0.85; CI 95%: 0.76-0.86; P=0.01) and arterial phase enhancement (HR: 0.3; CI 95%: 0.12-0.73; P=0.008) were associated with delayed progression. This large study confirms the previously reported results of TACE regarding its efficacy for the treatment of liver metastases of endocrine tumours. Arterial phase enhancement on abdominal CT and BMI are predictors of treatment's efficacy. Streptozotocin should be the preferred cytotoxic agent in order to save anthracycline for systemic chemotherapy.

Adult↗

[Effects of rigid-ankle and ankle-foot orthoses in the control of asymetrical undisturbed upright stance].

OBJECTIVE: To limit sensorimotor impairment associated with various diseases, devices aimed at easing such impairment are usually prescribed. A better knowledge of the specific effects of these devices in healthy subjects should help to assess the prescription. MATERIALS AND METHODS: Sixteen young healthy individuals were required to stand still on a double-force platform with an asymmetrical body weight distribution over the 2 legs and to reduce as much as possible their motions. Four conditions (1 used as reference without any orthosis and 3 with an ankle orthosis and 2 soft [ORP-S] and rigid [ORP-R] ankle-foot orthoses) were performed randomly. For each condition, 6 repetitions lasting 32 s were recorded. The centre-of-pressure trajectories from the loaded (CP(Cha)) and unloaded (CP(Déc)) feet and the resulting displacements (CP(Res)) were then computed along both the mediolateral (ML) and anteroposterior (AP) axes. Finally, these trajectories were analysed by their mean positions and parameters (Root Mean Square and Median Frequency) aimed at characterising their frequency spectra. RESULTS: Wearing the ORP-R model resulted in a backward shift of the mean position of the CP(Déc) trajectories, which had repercussions on CP(Res) values. In addition, frequency analysis showed decreased RMS for only the CP(Déc). DISCUSSION-CONCLUSION: We found effects linked to the physical features of various ankle orthoses tested. These effects can be observed because of the separate measure of the unloaded support. This data should improve the prescription of ankle-foot orthoses according to patient needs. These results should be viewed as a first step before their extension to study of patients with hemiparalysis, to improve their prescription in accordance with such patients' needs.

Adult↗

[Performing saccadic eye movements modifies postural control organisation].

AIMS OF THE STUDY: To assess to which extent performing saccadic eye movements modifies the postural strategies aimed at maintaining balance. MATERIALS AND METHODS: Twelve healthy adults were tested on a force platform in several conditions including one in which they were required to stare a visual target and four in which small and larger saccadic eyes movements were performed vertically and horizontally. The displacements of the centre of pressure (CP) were then processed through frequency analysis and modelled as fractional Brownian motion (fBm). Through the latter, one may objectively assess from which distance and after which delay corrective process are initiated. In addition, the degree with which the CP movement is successively controlled is determined. RESULTS: A decrease of the magnitudes of the CP trajectories is observed during saccades, especially along the anteroposterior axis. The fBm modelling emphasises the setting of a particular postural strategy whose main effect consists in more delayed corrective processes associated with a better capacity to control the corrective CP displacements. CONCLUSION: This particular strategy could be linked to the difficulty for the subjects to detect pertinent visual information in this very axis and/or an increased cognitive constraint due to the saccades. On the whole, these data underline the necessity, when performing postural protocols, to ask the patients to stare a visual target in order to limit their eye movements.

Adult↗

Does the capacity to appropriately stabilize trunk movements facilitate the control of upright standing?

This study was aimed at assessing the possible relationship between upright and sitting postures in healthy adults. The center of pressure trajectories from the force platform on which the subjects stood or sat were analyzed through a frequency analysis and modeled through the fractional Brownian motion framework. The same type of control process was involved during sitting and upright posture maintenance. Both upright and sitting posture would be controlled by the same mechanical law and/or by the same type of central process. Conversely, these two postures presented different characteristics and a relative independence. Both postures displayed specific biomechanical constraints and involved specific effectors, in particular along the anterior-posterior axis. Thus, performances in these two postures are completely independent in the anterior-posterior axis, whereas they are slightly linked in the medio-lateral axis. Improved trunk functions to improve postural stability have an interest solely to improve lateral stabilization.

Adult↗

[Immediate effects of physiotherapy session of lower limb by balneotherapy on postural control].

OBJECTIVE: The aim of this study was to compare the immediate effects of standard physiotherapy (S) and balneotherapy (B) on the postural capacity of subjects with lower-limb injuries. METHODS: The postural sway of 12 voluntary subjects was evaluated before (REF1 and REF2) and after two different physiotherapy sessions performed in the swimming pool (B) or under (S). The centre of pressure (CP) trajectory was recorded by use of a force platform. CP displacements in the mediolateral and anteroposterior axes were then separated into two elementary superimposed components: the horizontal motion of the centre of gravity (CG) and the difference between the CP and the vertical projection of the CG (CP-CG). The amplitude of the latter component (CP-CG) is thought to express neuromuscular activity. All trajectories were then analysed in terms of classical and frequency parameters. RESULTS: Postural sway did not differ before and after the physiotherapy sessions. Following both sessions, the mean CG velocity decreased significantly (P<0.5). The area of CP-CG trajectory was diminished solely by the aquatic exercise (P<0.5) and was associated with decreased amplitude of motion along the anteroposterior axis (P<0.05), which suggests decreased neuromuscular activity to maintain posture. CONCLUSION: Interestingly, decreased motion was observed along the anteroposterior axis, which corresponds to ankle movements. Exercising lower-limb muscles under water could reinforce proprioceptive input, resulting in a better postural control.

Adolescent↗

Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801).

BACKGROUND: The aim of this study was to evaluate the efficacy of adjuvant chemotherapy after resection for gastric cancer in a randomized controlled trial. PATIENTS AND METHODS: After curative resection, stage II-III-IVM0 gastric cancer patients were randomly assigned to postoperative chemotherapy or surgery alone. 5-Fluorouracil (5-FU) 800 mg/m(2) daily (5-day continuous infusion) was initiated before day 14 after resection. One month later, four 5-day cycles of 5-FU (1 g/m(2) per day) plus cisplatin (100 mg/m(2) on day 2) were administered every 4 weeks. RESULTS: The study was closed prematurely after enrollment of 260 patients (79.7% N+), owing to poor accrual. At 97.8 months median follow-up, 5- and 7-year overall survival were 41.9% and 34.9% in the control group versus 46.6% and 44.6% in the chemotherapy group (P=0.22). Cox model hazard ratios were 0.74 [95% confidence interval (CI) 0.54-1.02; P=0.063] for death and 0.70 (95% CI 0.51-0.97; P=0.032) for recurrence. An invaded/removed lymph nodes ratio >0.3 was the main independent poor prognostic factor identified by multivariate analysis (P=0.0001). Because of toxicity, only 48.8% of patients received more than 80% of the planned dose. CONCLUSION: There was no statistically significant survival benefit with this toxic cisplatin-based adjuvant chemotherapy, but a risk reduction in recurrence was observed.

Antineoplastic Combined Chemotherapy Protocols↗

Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986.

PURPOSE: To demonstrate that adding irinotecan to a standard weekly schedule of high-dose, infusional fluorouracil (FU) and leucovorin (folinic acid [FA]) can prolong progression-free survival (PFS). PATIENTS AND METHODS: Four hundred thirty patients with measurable or assessable metastatic colorectal cancer were randomly assigned to receive either FA 500 mg/m(2) as a 2-hour infusion and FU 2.6 g/m(2) by intravenous 24-hour infusion, both administered weekly for 6 weeks, followed by a 2-week rest (Arbeitsgemeinschaft für Internistische Onkologie [AIO] arm, n = 216), or a similar schedule but with FU 2.3 or 2.0 g/m(2) preceded by irinotecan 80 mg/m(2) administered over 30 minutes (experimental group, n = 214). RESULTS: The median PFS time in the experimental group was 8.5 months (95% CI, 7.6 to 9.9 months) compared with 6.4 months (95% CI, 5.3 to 7.2 months) in the AIO arm (P < .0001). The median overall survival time was increased from 16.9 to 20.1 months (P = .2779). The objective response rate was 62.2% (95% CI, 55.0% to 69.5%) in the experimental group and 34.4% (95% CI, 27.5% to 41.3%) in the AIO arm (P < .0001). CONCLUSION: The addition of irinotecan to the standard AIO FU/FA regimen was associated with a highly significant improvement in PFS and response rate and was well tolerated. The results of this study confirm that irinotecan in combination with high-dose infusional FU/FA is a reference first-line treatment.

Adult↗

Compatibility of postural behavior induced by two aspects of visual feedback: time delay and scale display.

Fourteen healthy adults were tested to assess the potential influence on stance maintenance of two parts of the visual feedback technique (display scale and time delay). The task consisted in their keeping a spot on the screen representing their center of pressure, CoP (i.e. successive points of application of the ground reaction forces detected by the force platform on which they were standing) to a minimum size. The analysis focused on elementary motions computed from the complex CoP trajectories, that is the horizontal motion of the center of gravity (CoG(h)) and the difference between the CoP and the vertical projection of the center of gravity (CoP-CoG(v)). The former is recognized as the main variable in postural control, and several interesting features can be extracted from the latter. The results indicate that setting a delay and increasing the display scale induce substantial reductions in CoP-CoG(v) and CoG(h) displacements, respectively. Interestingly, when the two effects are combined, these single effects cohabit quite happily. Fractional Brownian motion modeling of these trajectories revealed clearly that, in each case, these effects originate principally from poor or improved control, respectively. This feature confirms that these elementary motions are involved differently in the postural system and that study of the complex CoP might not be of great interest. By generating opposing but complementary trends, the visual feedback technique should thus be perceived as a promising tool for inducing particular postural behavior in healthy and disabled individuals.

Adult↗

Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases.

BACKGROUND: The aim of this case-matched study was to determine the best treatment strategy for patients with asymptomatic colorectal cancer and irresectable synchronous liver metastases. METHODS: Between 1997 and 2002, 27 patients with asymptomatic colorectal cancer and irresectable synchronous liver metastases were treated by chemotherapy without initial primary resection (chemotherapy group). These 27 patients were compared with 32 patients matched for age, sex, performance status, primary tumour location, number of liver metastases, nature of irresectable disease and type of chemotherapy, but who were treated initially by resection of primary tumour (resection group). RESULTS: The 2-year actuarial survival rate was 41 per cent in the chemotherapy group and 44 per cent in the resection group (P = 0.753). In the latter group, the mortality and morbidity rates for primary resection were 0 and 19 per cent (six of 32 patients) respectively. In the chemotherapy group, intestinal obstruction related to the primary tumour occurred in four of 27 patients. The mean overall hospital stay was 11 days in the chemotherapy group and 22 days in the resection group (P = 0.003). CONCLUSION: Systemic chemotherapy without resection of the bowel cancer is the option of choice because, for most patients, it is associated with a shorter hospital stay and avoids surgery without a detrimental effect on survival.

Antineoplastic Combined Chemotherapy Protocols↗

A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial.

UNLABELLED: Previous small phase II trials have demonstrated that the combination of 5-fluorouracil (5FU) and cisplatin(CDDP) could have clinical activity in metastatic biliary tract cancer. This randomised phase II trial was designed to assess the activity and safety of a high-dose infusional weekly 5FU alone (HDFU) and the combination of 5FU, folinic acid (FA) and CDDP. Patients were included if they had histologically proven locally advanced or metastatic biliary tract carcinoma, World Health Organisation (WHO) performance status < or = 2, bilirubin <2 x upper normal limit, adequate haematological and renal functions and had not received prior chemotherapy, even in the adjuvant setting. TREATMENTS: Arm A (HDFU) consisted of cycles of 5FU 3 g/m(2) intravenously (i.v.), 24 h infusion, weekly, for 6 weeks, followed by 1 week rest, every 7 weeks; Arm B (5FU+FA+CDDP) consisted of cycles of 5FU 2.0 g/m(2) i.v. with folinic acid 500 mg/m(2), 2 h-infusion, weekly, for 6 weeks, followed by 1 week rest plus cisplatin 50 mg/m(2), once every two weeks, for 6 weeks, followed by 1 week rest, every 7 weeks. From February 1997 to June 1999, 58 patients were randomised (29 in each arm). Patients had a median age of 58 years in Arm A and 62 years in Arm B, locally advanced disease was present in 21% of the patients in Arm A and 11% in Arm B. WHO performance status of 0/1/2 was noted in 48%/45%/7% of the patients in Arm A and 54%/43%/4% in Arm B. In both arms, the most common metastatic sites were the liver and peritoneum. Twenty-eight patients were eligible in each arm and one patient did not start the allocated therapy in Arm B. The median number of cycles was 2 [range 1-12] in Arm A and 2 [range 1-6] in Arm B. Responses for the eligible patients who started their allocated therapy were as follows: Complete Response (CR) 0% in Arm A, 4% in Arm B, Partial Response (PR) 7% in Arm A, 15% in Arm B resulting in an overall response rate [95% CI] of 7.1% in Arm A [0.9-23.5%] and 19% [6.3-38.1%] in Arm B. Disease stabilisation was observed in 46% in Arm A and 44% in Arm B. National Cancer Institute of Canada (NCIC) grade 3-4 adverse events (% of patients in Arm A/Arm B) were neutropenia 4%/26%, thrombopenia 0%/7%, stomatitis 0%/4%, vomiting 7%/14%, diarrhoea 0%/11% and neurotoxicity 4%/0%. There was one early toxic death in Arm B. The median overall survival (OS) [95% CI] was in Arm A/Arm B: 5.0 [4.0-7.4] months/8.0 [5.8-11.8] months and the median progression-free survival (PFS) was 3.3 [1.7-4.7] months/3.3 [2.3-6.7] months. Cisplatin in combination with 5FU+FA showed a higher activity than HDFU, but was more toxic. These results are not sufficient to start a phase III trial. However, our group is planning a phase III trial comparing 5FU+folinic acid versus the same schedule+oxaliplatin a platinum analogue.

Antineoplastic Combined Chemotherapy Protocols↗

Undisturbed upright stance control in the elderly: Part 1. Age-related changes in undisturbed upright stance control.

The authors investigated age-related changes in postural control in 33 healthy young adults (18-31 years), 29 seniors (62-75 years), and 22 elderly people (75-96 years). A force platform recorded the results. The horizontal motions of the center of gravity (CGh) and their difference in the plane of support CP - CGv were deduced from the complex center of pressure (CP) trajectories. With fractional Brownian modeling, one can establish that the aging process seems to induce a transition phase in which seniors take more time to initiate the corrective process in the mediolateral (ML) axis than do younger people. The elderly develop a new strategy characterized by the mobilization of higher neuromuscular energy to maintain equilibrium. In the ML axis, the larger displacements could be caused mainly by a hip strategy that could facilitate step initiation. In the anteroposterior (AP) axis, seniors and elderly individuals maintain a relative ability to stabilize their CG into the base of support compared with younger people.

Adolescent↗

Undisturbed upright stance control in the elderly: Part 2. Postural-control impairments of elderly fallers.

A common way of predicting falling risks in elderly people can be to study center of pressure (CP) trajectories during undisturbed upright stance maintenance. By estimating the difference between CP and center of gravity (CG) motions (CP - CGv), one can estimate the neuromuscular activity. The results of this study, which included 34 sedentary elderly persons aged over 75 years (21 fallers and 13 nonfallers), demonstrated significantly increased CGh and CP - CGv motions in both axes for the fallers. In addition, the fallers presented larger CGh motions in the mediolateral axis, suggesting an enlarged loading-unloading mechanism, which could have reflected the adoption of a step-initiating strategy. As highlighted by fractional Brownian motion modeling, the distance covered by the CP - CGv motions before the successive control mechanisms switched was enhanced for the fallers in both axes, therefore increasing the risk that the CG would be outside of the base of support.

Accidental Falls↗

Influence of an asymmetrical body weight distribution on the control of undisturbed upright stance.

Postural asymmetry in humans is generally associated with different pathologies. However, its specific influence on undisturbed upright stance is poorly understood. To evaluate its separate effects on each support, the centre of pressure (CP) displacements were recorded through two force platforms. In a second step, the complex resultant centre of pressure trajectories (CP(Res)) were computed and decomposed into two elementary components: the horizontal displacements of the centre of gravity (CG(h)) and the difference in the plane of support between the vertical projection of CG(h) and CP(Res) (CP-CG(v)). These motions were then processed through a frequency analysis and modelled as fractional Brownian motion to gain some additional insight into their spatio-temporal organisation. Ten healthy adults were tested in three conditions consisting of various weight distributions. The quality of the mechanism involved in the control of the unloaded support CP motions appears to decrease as the asymmetry becomes more pronounced. To be precise, larger increases of the CP displacements are observed for the unloaded support compared to the loaded one. As a result, the CP(Res) motions are themselves augmented in the ML direction, inducing in turn larger CG(h) and CP-CG(v) motions. Postural asymmetry thus constitutes an important constraint on the control of upright undisturbed stance by generating changes in the control of both supports and by reducing the efficiency of the hip load/unload mechanisms. On the other hand, by inducing larger body sways, postural asymmetry necessitates higher energy expenditure and the setting of particular control mechanisms.

Adult↗

Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials.

This study evaluates the efficacy of capecitabine using data from a large, well-characterised population of patients with metastatic colorectal cancer (mCRC) treated in two identically designed phase III studies. A total of 1207 patients with previously untreated mCRC were randomised to either oral capecitabine (1250 mg m(-2) twice daily, days 1-14 every 21 days; n=603) or intravenous (i.v.) bolus 5-fluorouracil/leucovorin (5-FU/LV; Mayo Clinic regimen; n=604). Capecitabine demonstrated a statistically significant superior response rate compared with 5-FU/LV (26 vs 17%; P<0.0002). Subgroup analysis demonstrated that capecitabine consistently resulted in superior response rates (P<0.05), even in patient subgroups with poor prognostic indicators. The median time to response and duration of response were similar and time to progression (TTP) was equivalent in the two arms (hazard ratio (HR) 0.997, 95% confidence interval (CI) 0.885-1.123, P=0.95; median 4.6 vs 4.7 months with capecitabine and 5-FU/LV, respectively). Multivariate Cox regression analysis identified younger age, liver metastases, multiple metastases and poor Karnofsky Performance Status as independent prognostic indicators for poor TTP. Overall survival was equivalent in the two arms (HR 0.95, 95% CI 0.84-1.06, P=0.48; median 12.9 vs 12.8 months, respectively). Capecitabine results in superior response rate, equivalent TTP and overall survival, an improved safety profile and improved convenience compared with i.v. 5-FU/LV as first-line treatment for MCRC. For patients in whom fluoropyrimidine monotherapy is indicated, capecitabine should be strongly considered. Following encouraging results from phase I and II trials, randomised trials are evaluating capecitabine in combination with irinotecan, oxaliplatin and radiotherapy. Capecitabine is a suitable replacement for i.v. 5-FU as the backbone of colorectal cancer therapy.

Administration, Oral↗